Aurobindo

Financial

Investors

Contact Person

Unaudited Quarterly Results for the First Quarter Ended 30th June 2006

(Rs.in Mio)

	First Quarter Ended		Year ended
Particulars	30.06.2006	30.06.2005	31.03.2006
	(Unaudited)	(Unaudited)	(Audited)
Net Sales/Income from Operations	4385.6	2806.6	14722.0
Other Income	171.1	35.8	303.5
Total Income	4556.7	2842.4	15025.5
Expenditure
a. (Increase) / Decrease in Stock in Trade	-445.1	-124.5	-275.3
b. Consumption of Raw Materials	2921.2	1813.9	9026.8
c. Staff Cost	258.0	182.9	792.2
d. Other Expenditure	992.7	703.8	3435.2
Total expenditure	3726.8	2576.1	12978.9
Profit Before Depreciation, Interest & Tax	829.9	266.3	2046.6
Interest	180.9	134.4	606.4
Depreciation	142.8	118.7	511.2
Profit before taxation	506.2	13.2	929.0
Provision for Taxation
a. Current Tax (MAT Provision)	58.1	1.7	90.1
b. MAT Credit Entitlement	-52.2	-	-80.9
c. Deferred Tax	137.4	-9.2	158.8
d. Fringe Benefit Tax	0.8	0.6	2.8
e. Tax adjustments of previous years	-	-	64.5
Total Tax	144.1	-6.9	235.3
Net Profit	362.1	20.1	693.7
Paid-up Equity Share Capital	266.35	253.85	266.35
(Face value Rs. 5 per share)
Reserves excluding Revaluation Reserves	-	-	8787.8
Basic Earnings per share (Rs.) (not annualised)	6.80	0.39	13.22
Diluted Earnings per share (Rs.) (not annualised)	5.73	0.39	12.46
Aggregate of Non-promoters Shareholding
a. Number of Shares	NA	NA	23557656
b. Percentage of Shareholding	NA	NA	44.22

Notes:
1.	The above unaudited results which are subjected to limited review by the Auditors of the Company, were reviewed by the Audit Committee and have been taken on record by the Board at its meeting held on 31.07.2006.
2.	The Company's operations fall within a single primary business segment viz. 'Pharmaceutical Products'.
3.	Investor complaintspending at the beginning of the quarter: Nil, received: 50, resolved: 50 and lying unresolved at the end of the quarter: Nil.
4.	Sales for the quarter include exports of Rs.1585.3 million (Rs.1294.5 million).
5.	During the quarter, Company has raised USD 200 Millions through issue of zero coupon Foreign Currency Convertible Bonds due 2011.
6.	Figures for the previous quarter have been rearranged wherever necessary.